-
1
-
-
84908504661
-
Temporal trends in populationbased death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years
-
Kim Y, Ejaz A, Tayal A, Spolverato G, Bridges JF, Anders RA, Pawlik TM: Temporal trends in populationbased death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer 2014;120:3058-3065.
-
(2014)
Cancer
, vol.120
, pp. 3058-3065
-
-
Kim, Y.1
Ejaz, A.2
Tayal, A.3
Spolverato, G.4
Bridges, J.F.5
Anders, R.A.6
Pawlik, T.M.7
-
2
-
-
84855955803
-
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
-
Wang JH, Wang CC, Hung CH, Chen CL, Lu SN: Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 2012;56:412-418.
-
(2012)
J Hepatol
, vol.56
, pp. 412-418
-
-
Wang, J.H.1
Wang, C.C.2
Hung, C.H.3
Chen, C.L.4
Lu, S.N.5
-
3
-
-
79952231921
-
American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update
-
Bruix J, Sherman M, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update. Hepatology 2011;53:1020-1022.
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
4
-
-
84984586846
-
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
-
Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK: Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-474.
-
(2010)
Hepatol Int
, vol.4
, pp. 439-474
-
-
Omata, M.1
Lesmana, L.A.2
Tateishi, R.3
Chen, P.J.4
Lin, S.M.5
Yoshida, H.6
Kudo, M.7
Lee, J.M.8
Choi, B.I.9
Poon, R.T.10
Shiina, S.11
Cheng, A.L.12
Jia, J.D.13
Obi, S.14
Han, K.H.15
Jafri, W.16
Chow, P.17
Lim, S.G.18
Chawla, Y.K.19
Budihusodo, U.20
Gani, R.A.21
Lesmana, C.R.22
Putranto, T.A.23
Liaw, Y.F.24
Sarin, S.K.25
more..
-
5
-
-
0037308133
-
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
-
Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003;37:429-442.
-
(2003)
Hepatology
, vol.37
, pp. 429-442
-
-
Llovet, J.M.1
Bruix, J.2
-
6
-
-
47949116252
-
SHARP investigators study group: Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
De Oliveira, A.C.7
Santoro, A.8
Raoul, J.L.9
Forner, A.10
Schwartz, M.11
Porta, C.12
Zeuzem, S.13
Bolondi, L.14
Greten, T.F.15
Galle, P.R.16
Seitz, J.F.17
Borbath, I.18
Häussinger, D.19
Giannaris, T.20
Shan, M.21
Moscovici, M.22
Voliotis, D.23
Bruix, J.24
more..
-
7
-
-
57749189578
-
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial
-
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009;10:25-34.
-
(2009)
Lancet Oncol
, vol.10
, pp. 25-34
-
-
Cheng, A.L.1
Kang, Y.K.2
Chen, Z.3
Tsao, C.J.4
Qin, S.5
Kim, J.S.6
Luo, R.7
Feng, J.8
Ye, S.9
Yang, T.S.10
Xu, J.11
Sun, Y.12
Liang, H.13
Liu, J.14
Wang, J.15
Tak, W.Y.16
Pan, H.17
Burock, K.18
Zou, J.19
Voliotis, D.20
Guan, Z.21
more..
-
8
-
-
33745271861
-
Effects of location and extension of portal vein tumor thrombus on long-Term outcomes of surgical treatment for hepatocellular carcinoma
-
Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF, Zhang BX, He SQ, Zhang WG: Effects of location and extension of portal vein tumor thrombus on long-Term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 2006;13:940-946.
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 940-946
-
-
Chen, X.P.1
Qiu, F.Z.2
Wu, Z.D.3
Zhang, Z.W.4
Huang, Z.Y.5
Chen, Y.F.6
Zhang, B.X.7
He, S.Q.8
Zhang, W.G.9
-
9
-
-
84905563720
-
Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma
-
Zhong JH, Ke Y, Gong WF, et al: Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg 2014;260:329-340.
-
(2014)
Ann Surg
, vol.260
, pp. 329-340
-
-
Zhong, J.H.1
Ke, Y.2
Gong, W.F.3
-
10
-
-
58849159660
-
Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: The J-HCC guidelines
-
(Suppl 19
-
Kokudo N, Makuuchi M: Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: The J-HCC guidelines. J Gastroenterol 2009;44(Suppl 19):119-121.
-
(2009)
J Gastroenterol
, vol.44
, pp. 119-121
-
-
Kokudo, N.1
Makuuchi, M.2
-
11
-
-
84859589351
-
European helicobacter study group: Management of helicobacter pylori infection the Maastricht IV/florence consensus report
-
Malfertheiner P, Megraud F, O?Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ, European Helicobacter Study Group: Management of Helicobacter pylori infection-The Maastricht IV/Florence Consensus Report. Gut 2012;61:646-664.
-
(2012)
Gut
, vol.61
, pp. 646-664
-
-
Malfertheiner, P.1
Megraud, F.2
Omorain, C.A.3
Atherton, J.4
Axon, A.T.5
Bazzoli, F.6
Gensini, G.F.7
Gisbert, J.P.8
Graham, D.Y.9
Rokkas, T.10
El-Omar, E.M.11
Kuipers, E.J.12
-
12
-
-
41849143148
-
Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma
-
(Suppl 2
-
Daniele B, Annunziata M, Barletta E, Tinessa V, Di Maio M: Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma. Hepatol Res 2007;37(Suppl 2):S206-S209.
-
(2007)
Hepatol Res
, vol.37
, pp. S206-S209
-
-
Daniele, B.1
Annunziata, M.2
Barletta, E.3
Tinessa, V.4
Di Maio, M.5
-
13
-
-
0038748320
-
Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score
-
Kudo M, Chung H, Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003;38:207-215.
-
(2003)
J Gastroenterol
, vol.38
, pp. 207-215
-
-
Kudo, M.1
Chung, H.2
Osaki, Y.3
-
14
-
-
15044356402
-
Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine green test
-
Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M: Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005;12:16-22.
-
(2005)
J Hepatobiliary Pancreat Surg
, vol.12
, pp. 16-22
-
-
Imamura, H.1
Sano, K.2
Sugawara, Y.3
Kokudo, N.4
Makuuchi, M.5
-
15
-
-
0030880567
-
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy
-
Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J: Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997;84:1255-1259.
-
(1997)
Br J Surg
, vol.84
, pp. 1255-1259
-
-
Lau, H.1
Man, K.2
Fan, S.T.3
Yu, W.C.4
Lo, C.M.5
Wong, J.6
-
16
-
-
0029833531
-
Hepatic resection of hepatocellular carcinoma in cirrhotic livers: Is it unjustified in impaired liver function?
-
Wu CC, Ho WL, Yeh DC, Huang CR, Liu TJ, P?eng FK: Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery 1996;120:34-39.
-
(1996)
Surgery
, vol.120
, pp. 34-39
-
-
Wu, C.C.1
Ho, W.L.2
Yeh, D.C.3
Huang, C.R.4
Liu, T.J.5
Peng, F.K.6
-
17
-
-
0029842080
-
Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure
-
Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodés J: Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-1022.
-
(1996)
Gastroenterology
, vol.111
, pp. 1018-1022
-
-
Bruix, J.1
Castells, A.2
Bosch, J.3
Feu, F.4
Fuster, J.5
Garcia-Pagan, J.C.6
Visa, J.7
Bru, C.8
Rodés, J.9
-
18
-
-
84862241705
-
Long-Term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria
-
Ho CM, Lee PH, Chen CL, Ho MC, Wu YM, Hu RH: Long-Term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria. Ann Surg Oncol 2012;19:826-833.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 826-833
-
-
Ho, C.M.1
Lee, P.H.2
Chen, C.L.3
Ho, M.C.4
Wu, Y.M.5
Hu, R.H.6
-
19
-
-
84907546760
-
Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension
-
Zhong JH, Li H, Xiao N, Ye XP, Ke Y, Wang YY, Ma L, Chen J, You XM, Zhang ZY, Lu SD, Li LQ: Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension. PLoS One 2014;9:e108755.
-
(2014)
PLoS One
, vol.9
, pp. e108755
-
-
Zhong, J.H.1
Li, H.2
Xiao, N.3
Ye, X.P.4
Ke, Y.5
Wang, Y.Y.6
Ma, L.7
Chen, J.8
You, X.M.9
Zhang, Z.Y.10
Lu, S.D.11
Li, L.Q.12
-
20
-
-
44649111962
-
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
-
Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N, Makuuchi M: Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 2008;134:1908-1916.
-
(2008)
Gastroenterology
, vol.134
, pp. 1908-1916
-
-
Ishizawa, T.1
Hasegawa, K.2
Aoki, T.3
Takahashi, M.4
Inoue, Y.5
Sano, K.6
Imamura, H.7
Sugawara, Y.8
Kokudo, N.9
Makuuchi, M.10
-
21
-
-
62149113300
-
Liver resection improves the survival of patients with multiple hepatocellular carcinomas
-
Ho MC, Huang GT, Tsang YM, Lee PH, Chen DS, Sheu JC, Chen CH: Liver resection improves the survival of patients with multiple hepatocellular carcinomas. Ann Surg Oncol 2009;16:848-855.
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 848-855
-
-
Ho, M.C.1
Huang, G.T.2
Tsang, Y.M.3
Lee, P.H.4
Chen, D.S.5
Sheu, J.C.6
Chen, C.H.7
-
22
-
-
85027932872
-
Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma
-
Lim C, Mise Y, Sakamoto Y, Yamamoto S, Shindoh J, Ishizawa T, Aoki T, Hasegawa K, Sugawara Y, Makuuchi M, Kokudo N: Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma. World J Surg 2014;38:2910-2918.
-
(2014)
World J Surg
, vol.38
, pp. 2910-2918
-
-
Lim, C.1
Mise, Y.2
Sakamoto, Y.3
Yamamoto, S.4
Shindoh, J.5
Ishizawa, T.6
Aoki, T.7
Hasegawa, K.8
Sugawara, Y.9
Makuuchi, M.10
Kokudo, N.11
-
23
-
-
0036252711
-
Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter
-
Poon RT, Fan ST, Wong J: Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 2002;194:592-602.
-
(2002)
J Am Coll Surg
, vol.194
, pp. 592-602
-
-
Poon, R.T.1
Fan, S.T.2
Wong, J.3
-
24
-
-
58749107000
-
Solitary large hepatocellular carcinoma: A specific subtype of hepatocellular carcinoma with good outcome after hepatic resection
-
Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F: Solitary large hepatocellular carcinoma: A specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 2009;249:118-123.
-
(2009)
Ann Surg
, vol.249
, pp. 118-123
-
-
Yang, L.Y.1
Fang, F.2
Ou, D.P.3
Wu, W.4
Zeng, Z.J.5
Wu, F.6
-
25
-
-
34648832051
-
Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection
-
Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC: Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 2007;14:2817-2823.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 2817-2823
-
-
Pandey, D.1
Lee, K.H.2
Wai, C.T.3
Wagholikar, G.4
Tan, K.C.5
-
26
-
-
84898879674
-
Long-Term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching
-
Min YW, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS: Long-Term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching. J Gastroenterol Hepatol 2014;29:1043-1048.
-
(2014)
J Gastroenterol Hepatol
, vol.29
, pp. 1043-1048
-
-
Min, Y.W.1
Lee, J.H.2
Gwak, G.Y.3
Paik, Y.H.4
Lee, J.H.5
Rhee, P.L.6
Koh, K.C.7
Paik, S.W.8
Yoo, B.C.9
Choi, M.S.10
-
27
-
-
84874234692
-
Impact of hepatectomy for huge solitary hepatocellular carcinoma
-
Ariizumi S, Kotera Y, Takahashi Y, Katagiri S, Yamamoto M: Impact of hepatectomy for huge solitary hepatocellular carcinoma. J Surg Oncol 2013;107:408-413.
-
(2013)
J Surg Oncol
, vol.107
, pp. 408-413
-
-
Ariizumi, S.1
Kotera, Y.2
Takahashi, Y.3
Katagiri, S.4
Yamamoto, M.5
-
28
-
-
43149123794
-
Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter
-
Shimada K, Sakamoto Y, Esaki M, Kosuge T: Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter. Langenbecks Arch Surg 2008;393:521-526.
-
(2008)
Langenbecks Arch Surg
, vol.393
, pp. 521-526
-
-
Shimada, K.1
Sakamoto, Y.2
Esaki, M.3
Kosuge, T.4
-
29
-
-
79952109611
-
Surgical technique: New advances for expanding indications and increasing safety in liver resection for HCC: The Eastern perspective
-
Ishizawa T, Mise Y, Aoki T, Hasegawa K, Beck Y, Sugawara Y, Kokudo N: Surgical technique: new advances for expanding indications and increasing safety in liver resection for HCC: The Eastern perspective. J Hepatobiliary Pancreat Sci 2010;17:389-393.
-
(2010)
J Hepatobiliary Pancreat Sci
, vol.17
, pp. 389-393
-
-
Ishizawa, T.1
Mise, Y.2
Aoki, T.3
Hasegawa, K.4
Beck, Y.5
Sugawara, Y.6
Kokudo, N.7
-
30
-
-
84873734083
-
Role of surgical resection for multiple hepatocellular carcinomas
-
Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI: Role of surgical resection for multiple hepatocellular carcinomas. World J Gastroenterol 2013;19:366-374.
-
(2013)
World J Gastroenterol
, vol.19
, pp. 366-374
-
-
Choi, S.H.1
Choi, G.H.2
Kim, S.U.3
Park, J.Y.4
Joo, D.J.5
Ju, M.K.6
Kim, M.S.7
Choi, J.S.8
Han, K.H.9
Kim, S.I.10
-
31
-
-
0031951505
-
Hepatic resection for bilobar multicentric hepatocellular carcinoma: Is it justified?
-
Wu CC, Ho WL, Lin MC, Yeh DC, Wu HS, Hwang CJ, Liu TJ, P?eng FK: Hepatic resection for bilobar multicentric hepatocellular carcinoma: is it justified? Surgery 1998;123:270-277.
-
(1998)
Surgery
, vol.123
, pp. 270-277
-
-
Wu, C.C.1
Ho, W.L.2
Lin, M.C.3
Yeh, D.C.4
Wu, H.S.5
Hwang, C.J.6
Liu, T.J.7
Peng, F.K.8
-
32
-
-
84871971732
-
International cooperative study group on hepatocellular carcinoma: Improved long-Term survival after major resection for hepatocellular carcinoma: A multicenter analysis based on a new definition of major hepatectomy
-
discussion 77
-
Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA: International Cooperative Study Group on Hepatocellular Carcinoma: Improved long-Term survival after major resection for hepatocellular carcinoma: A multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013;17:66-77; discussion 77.
-
(2013)
J Gastrointest Surg
, vol.17
, pp. 66-77
-
-
Andreou, A.1
Vauthey, J.N.2
Cherqui, D.3
Zimmitti, G.4
Ribero, D.5
Truty, M.J.6
Wei, S.H.7
Curley, S.A.8
Laurent, A.9
Poon, R.T.10
Belghiti, J.11
Nagorney, D.M.12
Aloia, T.A.13
-
33
-
-
0037225891
-
Hepatic resection for bilobar hepatocellular carcinoma: Is it justified?
-
Liu CL, Fan ST, Lo CM, Ng IO, Poon RT, Wong J: Hepatic resection for bilobar hepatocellular carcinoma: is it justified? Arch Surg 2003;138:100-104.
-
(2003)
Arch Surg
, vol.138
, pp. 100-104
-
-
Liu, C.L.1
Fan, S.T.2
Lo, C.M.3
Ng, I.O.4
Poon, R.T.5
Wong, J.6
-
34
-
-
84866391058
-
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
-
Bruix J, Raoul JL, Sherman M, Mazzaferro V, Bolondi L, Craxi A, Galle PR, Santoro A, Beaugrand M, Sangiovanni A, Porta C, Gerken G, Marrero JA, Nadel A, Shan M, Moscovici M, Voliotis D, Llovet JM: Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol 2012;57:821-829.
-
(2012)
J Hepatol
, vol.57
, pp. 821-829
-
-
Bruix, J.1
Raoul, J.L.2
Sherman, M.3
Mazzaferro, V.4
Bolondi, L.5
Craxi, A.6
Galle, P.R.7
Santoro, A.8
Beaugrand, M.9
Sangiovanni, A.10
Porta, C.11
Gerken, G.12
Marrero, J.A.13
Nadel, A.14
Shan, M.15
Moscovici, M.16
Voliotis, D.17
Llovet, J.M.18
-
35
-
-
84900308309
-
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: Propensity score analysis
-
Nakazawa T, Hidaka H, Shibuya A, Okuwaki Y, Tanaka Y, Takada J, Minamino T, Watanabe M, Kokubu S, Koizumi W: Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis. BMC Gastroenterol 2014;14:84.
-
(2014)
BMC Gastroenterol
, vol.14
, pp. 84
-
-
Nakazawa, T.1
Hidaka, H.2
Shibuya, A.3
Okuwaki, Y.4
Tanaka, Y.5
Takada, J.6
Minamino, T.7
Watanabe, M.8
Kokubu, S.9
Koizumi, W.10
-
36
-
-
79958061940
-
Long-Term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis
-
Nagano H, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Tomimaru Y, Osuga K, Umeshita K, Doki Y, Mori M: Long-Term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis. Oncology 2011;80:63-69.
-
(2011)
Oncology
, vol.80
, pp. 63-69
-
-
Nagano, H.1
Wada, H.2
Kobayashi, S.3
Marubashi, S.4
Eguchi, H.5
Tanemura, M.6
Tomimaru, Y.7
Osuga, K.8
Umeshita, K.9
Doki, Y.10
Mori, M.11
-
37
-
-
84875856038
-
Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: A meta-Analysis
-
Xue TC, Xie XY, Zhang L, Yin X, Zhang BH, Ren ZG: Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: A meta-Analysis. BMC Gastroenterol 2013;13:60.
-
(2013)
Bmc Gastroenterol
, vol.13
, pp. 60
-
-
Xue, T.C.1
Xie, X.Y.2
Zhang, L.3
Yin, X.4
Zhang, B.H.5
Ren, Z.G.6
-
38
-
-
0027056086
-
Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein
-
discussion 1177
-
Yamaoka Y, Kumada K, Ino K, Takayasu T, Shimahara Y, Mori K, Tanaka A, Morimoto T, Taki Y, Washida M, et al: Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein. World J Surg 1992;16:1172-1176, discussion 1177.
-
(1992)
World J Surg
, vol.16
, pp. 1172-1176
-
-
Yamaoka, Y.1
Kumada, K.2
Ino, K.3
Takayasu, T.4
Shimahara, Y.5
Mori, K.6
Tanaka, A.7
Morimoto, T.8
Taki, Y.9
Washida, M.10
-
39
-
-
79955636987
-
Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: A single institution experience
-
Yoshidome H, Takeuchi D, Kimura F, Shimizu H, Ohtsuka M, Kato A, Furukawa K, Yoshitomi H, Miyazaki M: Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: A single institution experience. J Am Coll Surg 2011;212:796-803.
-
(2011)
J Am Coll Surg
, vol.212
, pp. 796-803
-
-
Yoshidome, H.1
Takeuchi, D.2
Kimura, F.3
Shimizu, H.4
Ohtsuka, M.5
Kato, A.6
Furukawa, K.7
Yoshitomi, H.8
Miyazaki, M.9
-
40
-
-
84866489025
-
Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus
-
Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS, Lau WY: Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer 2012;118:4725-4736.
-
(2012)
Cancer
, vol.118
, pp. 4725-4736
-
-
Peng, Z.W.1
Guo, R.P.2
Zhang, Y.J.3
Lin, X.J.4
Chen, M.S.5
Lau, W.Y.6
-
41
-
-
48549100294
-
Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection
-
Tanaka K, Shimada H, Matsuo K, Takeda K, Nagano Y, Togo S: Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg 2008;32:1738-1747.
-
(2008)
World J Surg
, vol.32
, pp. 1738-1747
-
-
Tanaka, K.1
Shimada, H.2
Matsuo, K.3
Takeda, K.4
Nagano, Y.5
Togo, S.6
-
42
-
-
84886096614
-
Resection of hepatocellular carcinoma with macroscopic vascular invasion
-
Roayaie S, Jibara G, Taouli B, Schwartz M: Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol 2013;20:3754-3760.
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 3754-3760
-
-
Roayaie, S.1
Jibara, G.2
Taouli, B.3
Schwartz, M.4
-
43
-
-
84906315867
-
Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis
-
Kokudo T, Hasegawa K, Yamamoto S, Shindoh J, Takemura N, Aoki T, Sakamoto Y, Makuuchi M, Sugawara Y, Kokudo N: Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis. J Hepatol 2014;61:583-588.
-
(2014)
J Hepatol
, vol.61
, pp. 583-588
-
-
Kokudo, T.1
Hasegawa, K.2
Yamamoto, S.3
Shindoh, J.4
Takemura, N.5
Aoki, T.6
Sakamoto, Y.7
Makuuchi, M.8
Sugawara, Y.9
Kokudo, N.10
-
44
-
-
84884963142
-
Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium
-
Wakayama K, Kamiyama T, Yokoo H, Kakisaka T, Kamachi H, Tsuruga Y, Nakanishi K, Shimamura T, Todo S, Taketomi A: Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Oncol 2013;11:259.
-
(2013)
World J Surg Oncol
, vol.11
, pp. 259
-
-
Wakayama, K.1
Kamiyama, T.2
Yokoo, H.3
Kakisaka, T.4
Kamachi, H.5
Tsuruga, Y.6
Nakanishi, K.7
Shimamura, T.8
Todo, S.9
Taketomi, A.10
-
45
-
-
33846439369
-
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection
-
Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M: Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 2007;141:196-202.
-
(2007)
Surgery
, vol.141
, pp. 196-202
-
-
Yang, Y.1
Nagano, H.2
Ota, H.3
Morimoto, O.4
Nakamura, M.5
Wada, H.6
Noda, T.7
Damdinsuren, B.8
Marubashi, S.9
Miyamoto, A.10
Takeda, Y.11
Dono, K.12
Umeshita, K.13
Nakamori, S.14
Wakasa, K.15
Sakon, M.16
Monden, M.17
-
46
-
-
80051717035
-
Management of patients with hepatocellular carcinoma and extrahepatic metastasis
-
Lee HS: Management of patients with hepatocellular carcinoma and extrahepatic metastasis. Dig Dis 2011;29:333-338.
-
(2011)
Dig Dis
, vol.29
, pp. 333-338
-
-
Lee, H.S.1
-
47
-
-
33846609118
-
Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma
-
Kuo SW, Chang YL, Huang PM, Hsu HH, Chen JS, Lee JM, Lee PH, Lee YC: Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 2007;14:992-997.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 992-997
-
-
Kuo, S.W.1
Chang, Y.L.2
Huang, P.M.3
Hsu, H.H.4
Chen, J.S.5
Lee, J.M.6
Lee, P.H.7
Lee, Y.C.8
-
48
-
-
80052927028
-
Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors
-
Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H, Koike K: Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 2011;117:4475-4483.
-
(2011)
Cancer
, vol.117
, pp. 4475-4483
-
-
Uchino, K.1
Tateishi, R.2
Shiina, S.3
Kanda, M.4
Masuzaki, R.5
Kondo, Y.6
Goto, T.7
Omata, M.8
Yoshida, H.9
Koike, K.10
-
49
-
-
84863341402
-
Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases
-
Jung SM, Jang JW, You CR, Yoo SH, Kwon JH, Bae SH, Choi JY, Yoon SK, Chung KW, Kay CS, Jung HS: Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases. J Gastroenterol Hepatol 2012;27:684-689.
-
(2012)
J Gastroenterol Hepatol
, vol.27
, pp. 684-689
-
-
Jung, S.M.1
Jang, J.W.2
You, C.R.3
Yoo, S.H.4
Kwon, J.H.5
Bae, S.H.6
Choi, J.Y.7
Yoon, S.K.8
Chung, K.W.9
Kay, C.S.10
Jung, H.S.11
-
50
-
-
44449085884
-
Panel of Experts in HCC-Design Clinical Trials: Design and endpoints of clinical trials in hepatocellular carcinoma
-
Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ, Panel of Experts in HCC-Design Clinical Trials: Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008;100:698-711.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 698-711
-
-
Llovet, J.M.1
Di Bisceglie, A.M.2
Bruix, J.3
Kramer, B.S.4
Lencioni, R.5
Zhu, A.X.6
Sherman, M.7
Schwartz, M.8
Lotze, M.9
Talwalkar, J.10
Gores, G.J.11
|